Study of Inhaled Carbon Monoxide to Treat Idiopathic Pulmonary Fibrosis
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Joe GN Garcia, MD
University of Illinois at Chicago
Principal Investigator - Rosas O Ivan, MD
Brigham and Women's Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of California San Francisco
San Francisco, California, United States
- University of Chicago
Chicago, Illinois, United States
- University of Illinois Chicago
Chicago, Illinois, United States
- Tulane University
New Orleans, Louisiana, United States
- Brigham and Women'S Hospital
Boston, Massachusetts, United States
- University of Michigan
Ann Arbor, Michigan, United States
- Columbia University
New York, New York, United States
- University of Washington
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2011
- Primary completion
- 31 Oct 2014
- Completion
- 30 Apr 2015
- Last update posted
- 14 Jun 2017
- Registered enrollment
- 58
- Registry id
- NCT01214187
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.